Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Ginseng polysaccharides | GP, when a high dose of GP is fed to diabetic rats for 15 days, the formation of intermediates, including gypenoside XVII and gypenoside LXXV is inhibited, and only one pathway (Rb1-> Rd -> F2 -> CK) is identified | uncultured bacterium |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | uncultured bacterium | during transformation of Rb1 by diabetic rat intestinal microflora, five transformed products, including ginsenoside Rd, F2, CK, gypenoside XVII (G-XVII), and LXXV (G-LXXV), as well as three transformation pathways, are identified | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
uncultured bacterium | - |
from diabetic rat intestinal microflora via fresh feces | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
4-nitrophenyl-beta-D-glucopyranoside + H2O | - |
uncultured bacterium | 4-nitrophenol + D-glucopyranose | - |
? | |
ginsenoside F2 + H2O | - |
uncultured bacterium | ginsenoside C-K + D-glucopyranose | - |
? | |
ginsenoside Rb1 + H2O | cf. EC 3.2.1.192 or EC 3.2.1.195 | uncultured bacterium | ginsenoside Rd + D-glucopyranose | - |
? | |
ginsenoside Rb1 + H2O | - |
uncultured bacterium | gypenoside XVII + D-glucopyranose | - |
? | |
ginsenoside Rd + H2O | - |
uncultured bacterium | ginsenoside F2 + D-glucopyranose | - |
? | |
gypenoside LXXV + H2O | G-LXXV | uncultured bacterium | ginsenoside C-K + D-glucopyranose | - |
? | |
gypenoside XVII + H2O | G-XVII | uncultured bacterium | gypenoside LXXV + D-glucose | - |
? | |
gypenoside XVII + H2O | cf. EC 3.2.1.193 | uncultured bacterium | ginsenoside F2 + D-glucopyranose | - |
? | |
additional information | during transformation of Rb1 by diabetic rat intestinal microflora, five transformed products, including ginsenoside Rd, F2, CK, gypenoside XVII (G-XVII), and LXXV (G-LXXV), as well as three transformation pathways, are identified | uncultured bacterium | ? | - |
? | |
additional information | when a high dose of Ginseng polysaccharides is fed to diabetic rats for 15 days, the formation of intermediates, including gypenoside XVII and gypenoside LXXV is inhibited, and only one pathway (Rb1-> Rd -> F2 -> CK) is identified, cf. EC 3.2.1.192 or EC 3.2.1.195. Mass spectrometric identification of substrates and products, overview | uncultured bacterium | ? | - |
? |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | uncultured bacterium |
General Information | Comment | Organism |
---|---|---|
metabolism | pathways of ginsenoside Rb1 biotransformation in diabetic rat intestinal microflora, overview. The first is Rb1 -> Rd -> F2 -> CK. The second pathway is Rb1 -> G-XVII -> G-LXXV -> CK. The third pathway is Rb1 -> G-XVII -> F2 -> CK. Ginseng polysaccharides restore the dysbiosis of intestinal flora in diabetic rats | uncultured bacterium |